Quick Answer
IceCure Medical Ltd. reported R&D Expense of $7.43 million for fiscal year 2025.
IceCure Medical Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $7.43M | +4.7% |
| 2024 | $7.10M | -14.2% |
| 2023 | $8.27M | -9.3% |
| 2022 | $9.12M | +55.2% |
| 2021 | $5.88M | +54.3% |
| 2020 | $3.81M | — |
- IceCure Medical Ltd. showed an increase of +4.7% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, IceCure Medical Ltd.’s r&d expense has grown by 95.1% (from $3.81 million to $7.43 million).
- The most recent figure is from IceCure Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: